Researchers at the Spanish National Cancer Research Centre (CNIO) published proof-of-principle results showing a role for telomerase reverse transcriptase (TERT) in demonstrating the feasibility of gene therapy in delaying physiological aging and extending longevity in normal mice.
View the original article here: Gene Therapy Briefs – Genetic Engineering News